Volume is like a 'polygraph test.'
Over the past nine reports, HAL has closed red seven times with another essentially being flat.
A few technical events are now casting some minor clouds.
Netflix is bullish, but faces key resistance before it can make a big run higher.
Citi is severely undervalued, even as financials underperform.
Selling isn't too heavy, but neither is buying as markets appear ready to doze off -- looks like a pullback is in order.
We are getting wholesale differences in the interpretation of the future trajectory of domestic economic growth.
At the very least, the valuation may be morphing from traditional old school media to a blend of media and tech.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Negative political pressure is being felt in an overbearing way on the entire healthcare sector.
Despite cries that call for Medicare for All is causing declines, early readings showed creep toward Realization Day for sector.
There's a key level to watch.
If I had a bias for SKX it would be on the long side.
This year we are seeing natural gas prices slump despite seasonal support.
What you want to know is what to do with the stocks.
Forward P/E ratios are approaching fair value -- which may slow the pace of progress.
China reported positive data, bolstering markets. Netflix had a beat on earnings, but faces fierce competition ahead. CSX is a thing of beauty.
The Investors Intelligence Bulls hit 54.9%, so close to that turning point of 55%, when the spiral upward to frothy starts.
NFLX reports earnings after the close on Tuesday.
This is not a stock you want to play around with on the long side.
UNH is best in class, but the class has problems.
Screening Goldman Sachs' list of the top 20 stocks to see which ones are the best technical opportunities.
When Netflix reports earnings tonight, what will likely matter above all else for now will be subscriber growth.
Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.
With vigorous volume, the stock has broken through resistance in response to a positive earnings preannouncement.
I'd lean towards playing a banking ETF here since the patterns are similar between C and one like XLF.
The biggest challenge is even if JNJ beats and raises guidance, the overhang of litigation could still prevent overzealous trading.
Should the global economic picture improve this stock will pop more than most.
Stock may pause a bit after its big 10% move up over the last three weeks.
Breathe easy, breadth is still strong.